Accessibility Menu
Evotec Se logo

Evotec Se

(OTC) EVOTF

Current Price$6.69
Market Cap$1.19B
Since IPO (2004)+86%
5 Year-85%
1 Year-19%
1 Month+28%

Evotec Se Financials at a Glance

Market Cap

$1.19B

Revenue (TTM)

€745.54M

Net Income (TTM)

-€194.35M

EPS (TTM)

-$1.27

P/E Ratio

-5.27

Dividend

$0.00

Beta (Volatility)

0.16 (Low)

Price

$6.69

Volume

2

Open

$6.49

Previous Close

$6.69

Daily Range

$6.49 - $6.69

52-Week Range

$4.73 - $8.58

Estimated Earnings Date

Aug 13, 2026

EVOTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evotec Se

Industry

Life Sciences Tools and Services

Employees

4,526

CEO

Christian Wojczewski, PhD

Headquarters

Hamburg, 22419, DE

EVOTF Financials

Key Financial Metrics (TTM)

Gross Margin

11%

Operating Margin

-14%

Net Income Margin

-26%

Return on Equity

-25%

Return on Capital

-9%

Return on Assets

-12%

Earnings Yield

-18.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.19B

Shares Outstanding

177.62M

Volume

2

Avg. Volume

23.781

Financials (TTM)

Gross Profit

€65.21M

Operating Income

-€140.82M

EBITDA

-€41.38M

Operating Cash Flow

-€9.43M

Capital Expenditure

-€72.51M

Free Cash Flow

-€81.95M

Cash & ST Invst.

€476.21M

Total Debt

€447.52M

Evotec Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€157.24M

-21.4%

Gross Profit

-€1.57M

-105.8%

Gross Margin

-1.00%

N/A

Market Cap

$1.19B

N/A

Market Cap/Employee

$249.32K

N/A

Employees

4,766

N/A

Net Income

-€122.40M

-287.6%

EBITDA

-€31.74M

-15.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

€57.52M

+157.5%

Accounts Receivable

€167.69M

-24.2%

Inventory

€33.11M

-1.2%

Long Term Debt

€299.98M

N/A

Short Term Debt

€88.95M

+46.0%

Return on Assets

-11.82%

N/A

Return on Invested Capital

-8.50%

N/A

Free Cash Flow

-€6.33M

+88.2%

Operating Cash Flow

-€2.15M

+93.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LJUIFSSY Group Limited
$0.40+0.00%
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$1.08+0.00%
CMOPFCosmo Pharmaceuticals N.V.
$93.62+5.19%
NPPNYNippon Shinyaku Co., Ltd.
$6.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$16.62-0.01%
STISolidion Technology
$22.71+3.51%
BBBlackBerry
$10.34+0.02%
FOXXFoxx Development
$5.25+0.84%

Questions About EVOTF

What is the current price of Evotec Se?

Evotec Se is trading at $6.69 per share.

What is the 52-week range for Evotec Se?

Over the past 52 weeks, Evotec Se has traded between $4.73 and $8.58.

How much debt does Evotec Se have?

As of the most recent reporting period, Evotec Se reported total debt of €446.43M.

How much cash does Evotec Se have on hand?

Evotec Se reported €446.95M in cash and cash equivalents in its most recent financial results.

What is Evotec Se’s dividend yield?

Evotec Se does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.